MapLight Therapeutics, Inc.(MPLT)
$6.42-0.23 (-3.46%)
MPLT
MapLight Therapeutics, Inc. financials statements
$6.42
At close:-0.23 (-3.46%)
Want to see MPLT full AI Analyst Report?
MapLight Therapeutics, Inc. (MPLT) Ratios
38 Followers
MapLight Therapeutics, Inc. Ratios
MPLT's free cash flow for Q3 2026 was $-35.69M. For the 2026 fiscal year, MPLT's free cash flow was decreased by $-12.00K and operating cash flow was $-35.68M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|---|
| Liquidity Ratios | ||||
| Current Ratio | 20.01 | 7.20 | 5.69 | 2.54 |
| Quick Ratio | 20.01 | 7.20 | 5.69 | 2.54 |
| Cash Ratio | 2.88 | 2.40 | 5.43 | 2.20 |
| Solvency Ratio | -7.60 | -3.54 | -2.74 | -1.59 |
| Operating Cash Flow Ratio | -8.51 | -4.95 | -3.54 | -2.11 |
| Short-Term Operating Cash Flow Coverage | -155.04 | -101.30 | -105.06 | -76.37 |
| Net Current Asset Value | $ 303.53M | $ 92.88M | $ 63.48M | $ 13.51M |
| Leverage Ratios | ||||
| Debt-to-Assets Ratio | 0.01 | 0.05 | 0.06 | 0.16 |
| Debt-to-Equity Ratio | 0.01 | 0.06 | 0.08 | 0.30 |
| Debt-to-Capital Ratio | 0.01 | 0.05 | 0.08 | 0.23 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.05 | 1.19 | 1.28 | 1.89 |
| Debt Service Coverage Ratio | -180.22 | -98.82 | -111.42 | -84.60 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.13 | 0.16 | 0.14 | 0.15 |
| Net Debt to EBITDA | 0.25 | 0.41 | 1.34 | 0.73 |
| Profitability Margins | ||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 95.31% | 93.53% | 97.25% | 96.07% |
| Return on Assets (ROA) | -33.61% | -56.66% | -60.94% | -76.20% |
| Return on Equity (ROE) | -35.16% | -67.35% | -78.15% | -143.82% |
| Return on Capital Employed (ROCE) | -36.50% | -68.55% | -74.67% | -116.62% |
| Return on Invested Capital (ROIC) | -36.43% | -68.11% | -74.19% | -115.12% |
| Return on Tangible Assets | -33.61% | -56.66% | -60.94% | -76.20% |
| Earnings Yield | -20.83% | -10.21% | -7.33% | -3.95% |
| Efficiency Ratios | ||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.37 | 0.17 | 0.16 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -995.55 | -2133.54 | -2286.02 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 995.55 | 2133.54 | 2286.02 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | ||||
| Operating Cash Flow Per Share | -3.14 | -1.90 | -1.26 | -0.64 |
| Free Cash Flow Per Share | -3.15 | -1.92 | -1.27 | -0.66 |
| Dividend Paid and CapEx Coverage Ratio | -292.04 | -102.36 | -112.57 | -35.63 |
| Capital Expenditure Coverage Ratio | -292.04 | -102.36 | -112.57 | -35.63 |
| Operating Cash Flow Coverage Ratio | -23.81 | -11.98 | -8.78 | -4.24 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -17.92% | -10.47% | -6.91% | -3.60% |
| Valuation Ratios | ||||
| Price-to-Earnings (P/E) Ratio | -4.80 | -9.81 | -13.64 | -25.31 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.69 | 6.60 | 10.66 | 36.41 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.58 | -9.55 | -14.48 | -27.81 |
| Price-to-Operating Cash Flow Ratio | -5.60 | -9.64 | -14.61 | -28.59 |
| Price-to-Earnings Growth (PEG) Ratio | -0.05 | -0.25 | -0.16 | 0.00 |
| Enterprise Value Multiple | -4.56 | -9.47 | -12.44 | -25.08 |
| Enterprise Value | 732.58M | 728.13M | 685.96M | 738.41M |
| EV to EBITDA | -4.56 | -9.47 | -12.44 | -25.08 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -5.29 | -9.15 | -13.07 | -27.03 |
| EV to Operating Cash Flow | -5.30 | -9.24 | -13.19 | -27.78 |
| Tangible Book Value Per Share | 10.41 | 2.78 | 1.72 | 0.50 |
| Shareholders’ Equity Per Share | 10.41 | 2.78 | 1.72 | 0.50 |
| Tax and Other Ratios | ||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -3.66 | -1.87 | -1.34 | -0.72 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.86 | 1.02 | 0.93 | 0.89 |
Currency in USD

